Apoptosis Repressor With Caspase Recruitment Domain Ameliorates Amyloid-Induced β-Cell Apoptosis and JNK Pathway...

Area of Science:

• Endocrinology
• Molecular Biology
• Cell Biology

Background:

• Islet amyloid, a hallmark of type 2 diabetes, drives beta-cell dysfunction and apoptosis.
• Apoptosis repressor with caspase recruitment domain (ARC) is expressed in islet beta cells and regulates apoptosis pathways.

Purpose of the Study:

• To investigate the role of ARC in islet amyloidosis and its impact on beta-cell apoptosis.
• To determine if ARC modulates the c-Jun N-terminal kinase (JNK) pathway in the context of islet amyloid.

Main Methods:

• Utilized a human islet amyloid polypeptide transgenic mouse model.
• Employed ARC knockdown and overexpression techniques in islet beta cells.
• Analyzed beta-cell apoptosis, islet amyloid deposition, and JNK pathway activation.
• Performed immunoprecipitation to assess ARC-JNK interaction.

Main Results:

• ARC knockdown exacerbated amyloid-induced beta-cell apoptosis and loss.
• ARC overexpression protected beta cells by reducing apoptosis without altering amyloid deposition.
• ARC overexpression suppressed JNK pathway activation, including c-Jun phosphorylation and target gene expression.
• Demonstrated physical interaction between ARC and JNK in mouse islet lysates.

Conclusions:

• ARC acts downstream of islet amyloid formation to regulate beta-cell apoptosis.
• ARC overexpression mitigates amyloid-induced beta-cell apoptosis by inhibiting the JNK pathway.
• Targeting ARC may represent a therapeutic strategy to reduce beta-cell loss in type 2 diabetes.